Received: 14 July 2019
Accepted: 4 February 2021
First Online: 18 February 2021
Ethics approval and consent to participate
: The study protocol conforms to the ethical guidelines of the Declaration of Helsinki as reflected in a prior approval by the Institution's human research committee of Algarve University Hospital Center (22/07/2016). Patients signed an informed consent form prior to inclusion in the study. All data was collected anonymously, and no association could be established between the questionnaires and the responders.
: Not applicable.
: F.M has received consultation fees outside of this research by Abbvie, MSD, Falk Foundation e.V., Ferring, Takeda, Pfizer, Vifor, Lab. Vito’Ria. For the remaining authors there are no conflicting interests.